Clinical reference laboratory services usually refer to a series of services provided by professional medical institutions or laboratories to assist doctors in the diagnosis, treatment, and monitoring of patients’ health status. These services typically include testing and analysis of various biomarkers, genetic markers, cytological samples, etc., to provide detailed information about the patients’ health status.
Global Clinical Reference Laboratory Service Segmentation Market Analysis
In terms of product types, clinical chemistry research trials play an important role. With the acceleration of new drug development and the rise of personalized healthcare, the demand for clinical chemistry research trials will continue to increase. It is expected that in the coming years, this field will continue to maintain rapid growth and its share will further expand.
From an application perspective, hospitals serve as the largest market for clinical reference laboratories. According to our research data, the estimated application scale of clinical reference laboratory services in hospitals in 2023 is $56.33 billion, and the market share is expected to reach 46.65%.
Global Clinical Reference Laboratory Service Market Size and Share Forecast by Type and Application in 2023
|
Market Size (Billion USD) |
Market Share |
Segmented by Type |
||
Clinical Chemistry |
56.89 |
47.11% |
Human and Tumor Genetics |
21.89 |
18.13% |
Medical Microbiology and Cytology |
31.91 |
26.43% |
Others |
10.06 |
8.33% |
Segmented by Application |
||
Clinics |
12.78 |
10.58% |
Hospitals |
56.33 |
46.65% |
Government Agencies |
11.67 |
9.66% |
Insurance Companies |
15.93 |
13.19% |
Pharmaceuticals & Biotechnology Companies |
10.26 |
8.49% |
Others |
13.79 |
11.42% |
Source: www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.